BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19834055)

  • 1. The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients.
    Barraclough DL; Platt-Higgins A; de Silva Rudland S; Barraclough R; Winstanley J; West CR; Rudland PS
    Am J Pathol; 2009 Nov; 175(5):1848-57. PubMed ID: 19834055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker.
    Salmans ML; Zhao F; Andersen B
    Breast Cancer Res; 2013 Apr; 15(2):204. PubMed ID: 23635006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of a novel metastasis-inducing protein human anterior gradient-2 (AGR2) in breast cancer and its clinical and prognostic significance].
    Wu ZS; Wu Q; Ding XD; Wang HQ; Shen YX; Fang SY
    Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):109-13. PubMed ID: 18681322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
    Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
    Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
    Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
    Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast Cancer.
    Lacambra MD; Tsang JY; Ni YB; Chan SK; Tan PH; Tse GM
    Ann Surg Oncol; 2015 Oct; 22(11):3489-96. PubMed ID: 25663596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
    Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
    Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.
    Xiu B; Chi Y; Liu L; Chi W; Zhang Q; Chen J; Guo R; Si J; Li L; Xue J; Shao ZM; Wu ZH; Huang S; Wu J
    Mol Cancer; 2019 Dec; 18(1):187. PubMed ID: 31856843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients.
    Innes HE; Liu D; Barraclough R; Davies MP; O'Neill PA; Platt-Higgins A; de Silva Rudland S; Sibson DR; Rudland PS
    Br J Cancer; 2006 Apr; 94(7):1057-65. PubMed ID: 16598187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.
    Valladares-Ayerbes M; Blanco-Calvo M; Reboredo M; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Díaz-Prado S; Medina V; Santamarina I; Pértega S; Figueroa A; Antón-Aparicio LM
    Int J Mol Sci; 2012; 13(4):4367-4387. PubMed ID: 22605983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients.
    Zhang Y; Forootan SS; Liu D; Barraclough R; Foster CS; Rudland PS; Ke Y
    Prostate Cancer Prostatic Dis; 2007; 10(3):293-300. PubMed ID: 17457305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response.
    Zakaria R; Platt-Higgins A; Rathi N; Crooks D; Brodbelt A; Chavredakis E; Lawson D; Jenkinson MD; Rudland PS
    Br J Cancer; 2016 May; 114(10):1101-8. PubMed ID: 27100728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of anterior gradient 2 and estrogen receptor-α: Dual critical roles in enhancing fulvestrant resistance and IGF-1-induced tumorigenesis of breast cancer.
    Li Z; Zhu Q; Chen H; Hu L; Negi H; Zheng Y; Ahmed Y; Wu Z; Li D
    Cancer Lett; 2016 Jul; 377(1):32-43. PubMed ID: 27063095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of anterior gradient-2 expression is an independent prognostic factor in colorectal carcinomas.
    Riener MO; Thiesler T; Hellerbrand C; Amann T; Cathomas G; Fritzsche FR; Dahl E; Bahra M; Weichert W; Terracciano L; Kristiansen G
    Eur J Cancer; 2014 Jul; 50(10):1722-1730. PubMed ID: 24794000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients.
    Wang G; Platt-Higgins A; Carroll J; de Silva Rudland S; Winstanley J; Barraclough R; Rudland PS
    Cancer Res; 2006 Jan; 66(2):1199-207. PubMed ID: 16424059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer.
    Zhou M; Gan XL; Ren YX; Chen QX; Yang YZ; Weng ZJ; Zhang XF; Guan JX; Tang LY; Ren ZF
    BMC Cancer; 2023 Aug; 23(1):743. PubMed ID: 37568077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.
    Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS
    Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of KAI1 and AGR2 in lung adenocarcinoma and their clinicopathological significance.
    Ci H; Wu L
    Medicine (Baltimore); 2022 Dec; 101(51):e32498. PubMed ID: 36595821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of AGR2 expression in breast cancer.
    Fritzsche FR; Dahl E; Pahl S; Burkhardt M; Luo J; Mayordomo E; Gansukh T; Dankof A; Knuechel R; Denkert C; Winzer KJ; Dietel M; Kristiansen G
    Clin Cancer Res; 2006 Mar; 12(6):1728-34. PubMed ID: 16551856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
    Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
    J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.